Detalles de la búsqueda
1.
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
Blood;
136(13): 1499-1506, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32603426
2.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica;
106(6): 1599-1607, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499241
3.
HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Nonmalignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant;
26(7): 1332-1341, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234377
4.
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources.
Biol Blood Marrow Transplant;
25(5): 1045-1052, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30500442
5.
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.
Blood;
127(2): 260-7, 2016 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26527675
6.
Novel lineage depletion preserves autologous blood stem cells for gene therapy of Fanconi anemia complementation group A.
Haematologica;
103(11): 1806-1814, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29976742
7.
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.
Biol Blood Marrow Transplant;
23(10): 1669-1677, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28602958
8.
Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment.
Biol Blood Marrow Transplant;
23(11): 1817-1825, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28754544
9.
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis.
Cancer;
122(19): 3005-3014, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27315441
10.
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
Blood;
124(16): 2596-606, 2014 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25161269
11.
Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens.
Blood;
123(10): 1615-20, 2014 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24435046
12.
Donor and recipient sex in allogeneic stem cell transplantation: what really matters.
Haematologica;
101(10): 1260-1266, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27354023
13.
Pediatric-inspired therapy compared to allografting for Philadelphia chromosome-negative adult ALL in first complete remission.
Am J Hematol;
91(3): 322-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26701142
14.
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
Blood;
122(22): 3651-8, 2013 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23982174
15.
Severe combined immunodeficiency (SCID) presenting with neonatal aplastic anemia.
Pediatr Blood Cancer;
62(11): 2047-9, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26011426
16.
Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report.
Biol Blood Marrow Transplant;
20(5): 617-21, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508838
17.
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.
Biol Blood Marrow Transplant;
20(12): 1996-2003, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25196857
18.
Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.
Biol Blood Marrow Transplant;
20(1): 89-97, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24161923
19.
A perspective on the selection of unrelated donors and cord blood units for transplantation.
Blood;
120(2): 259-65, 2012 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22596257
20.
A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.
Haematologica;
99(10): 1624-31, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25085357